Print

New Vector Control Products Urgently Needed to Combat Insecticide Resistance, UNITAID Report Warns

on .

Geneva – December 2014.  With a growing intensity and increasing geographical spread of insecticide resistance, UNITAID’s Malaria Vector Control Landscape highlights the need to stimulate product innovation for new solutions to tackle issue of malaria-carrying mosquitos.  It suggests that this could be achieved through increased financing  for R&D for vector control products, given that the vector control market is not seen as an attractive commercial target by industry.  The report also indicates that further measures to accelerate acceptance and uptake of new products in the market may also be needed, particularly as new products are likely to be more expensive than existing intervention tools.

Print

UNITAID Finds Affordability, Availability and Demand Slow Access to HIV Prevention Products

on .

Geneva – 28 November 2014. UNITAID has published its 2014 HIV Preventives Technology and Market Landscape which shows that although there has been a significant increase in products with promise to curb HIV transmission, scaling up access to them has been slow due to a variety of issues including affordability, availability and demand – all market based.  The report highlights opportunities to change this through efforts to reduce various market obstacles such as the lack of product approval completion.

Although the number of new HIV infections fell by 38% from 2001 to 2013, the number of new infections remains high, with over 2 million people newly infected in 2013 alone.  With AIDS as the sixth leading cause of death globally and the number one cause of death in sub-Saharan Africa, preventing new cases of HIV infection needs to remain a major global health priority.  Preventative tools can substantially contribute if made widely available.

Print

UNITAID’s EXPAND-TB and TBXpert MTB-RIF Projects Detect Over A Quarter of all MDR-TB Cases

on .

Makes Significant Contribution to WHO’s estimate of 30% Increase In Case Detection

Geneva, 22nd October 2014 – UNITAID welcomes new data in the World Health Organization’s new global report on tuberculosis (TB) which shows a 30% increase in case detection of multi-drug resistant TB (MDR-TB) in 2013, much of which is attributed to the roll out of the UNITAID-funded EXPAND-TB and TBXpert projects.

Print

Support Builds For Japan’s Adoption of the Air Ticket Levy at the Terashima Commission

on .

Tokyo, 12 October 2014 - Discussions on Japan’s possible adoption of the innovative air ticket levy continued today in Tokyo at a symposium to commemorate the launch of the Second Terashima Commission.  The Commission, a multi-sectoral coalition advocating for Japan to agree to the Solidarity Levy, includes parliamentarians, academics, civil society groups, trade unions, private sector and international organizations. Delegates were urged to help convince Japanese authorities that the country should come on board and implement the air ticket cooperation charge, as a first step to a wider but more complex contribution such as through the Financial Transaction Tax.  The campaign has already received widespread support under the leadership of the Parliamentary group chaired by Mr Seishiro Eto and been actively promoted by Mr Michihiro Ishibashi with the crucial support of Mr Tetsuji Tanaka from the International Solidarity Levy group (ISL).

Print

UNITAID Tuberculosis Medicines Technology and Market Landscape (Second Edition)

on .

Geneva – 09 October 2014 UNITAID has released the second edition of its TB Medicines Technology and Market Landscape, detailing current shortcomings in the tuberculosis (TB) medicines market and opportunities to improve access to lifesaving TB treatment.

Although largely curable, TB remains a serious threat to global public health and a leading cause of death, particularly among people co-infected with HIV and women of reproductive age. TB is also one of the top 10 causes of death in children.

Print

Tuberculosis diagnostics technology and market landscape – 3rd edition

on .

Geneva – 26 September 2014. UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use in decentralized settings than the current tools used by the majority of high-burden TB countries.

Print

Leading Group on Innovative Financing for Development

on .

24th September 2014 - Chair of the UNITAID Executive Board and United Nations Secretary General's Special Advisor on Innovative Financing for Development, Philippe Douste-Blazy, gave an opening address at the Leading Group on Innovative Financing for Development in New York.  The event's theme was "Innovative financing: a solution to diversify the financial toolbox for sustainable development and the climate".

Print

A Vision for 2030

on .

23rd September 2014 - UNITAID’s Chair of the Executive Board, Philippe Douste-Blazy joined other high level guests at the ‘A Vision for 2030’ event in New York, held during the week of the 69th UN General Assembly in the lead up to the 3rd Annual Global Citizen Festival to honour people fighting extreme poverty and working for an AIDS-free generation.  Dr Douste-Blazy spoke on the clear link between AIDS and poverty and the need for concerted action.

Print

UNITAID is celebrating its 8th anniversary

on .

19th September – on the eve of the 69th United National General Assembly, UNITAID is celebrating its 8th anniversary.  It was in 2006 at the opening of the 61st UNGA that UNITAID was officially launched by Brazil, France, Chile, Norway and the United Kingdom.

Print

Fourth Edition of the HIV/AIDS Diagnostic Technology Landscape

on .

Geneva - 15 July 2014 - UNITAID has released its Fourth Edition of the HIV Diagnostic Technology Landscape, the global health community’s key reference on the pipeline of promising new technologies to detect and monitor HIV treatment in resource-constrained settings. First released in June 2011 and updated annually, this report is used by health care providers, donors and developers to help guide the future response to the disease.

This current edition is being released as the 20th International AIDS conference begins in Melbourne, Australia. You can access it here.

Grantees

  • partners-EN-1
  • partners-EN-2
  • partners-EN-3